Why did you continue taking aspirin in spite of stomach issues?

Why Patients Keep Taking Aspirin Despite Stomach Problems

Many people continue low-dose aspirin for heart protection, as the cardiovascular benefits often outweigh the risk of gastrointestinal (GI) issues like stomach pain, ulcers, or bleeding. Doctors weigh this based on individual risk factors—high heart disease risk means stopping could increase chances of heart attack or stroke more than aspirin harms the stomach.[1]

How Aspirin Causes Stomach Issues

Aspirin blocks COX-1 enzymes, reducing protective stomach mucus and increasing acid damage. This leads to irritation in 10-20% of users and serious bleeding in 1-2% yearly, especially in those over 60 or on other meds like NSAIDs.[2]

Common Reasons to Continue Anyway

• Proven heart benefits: Daily 81mg aspirin cuts heart attack risk by 20-30% in high-risk patients, per guidelines from the American Heart Association.[3]
  
• No good alternatives for some: Switching to enteric-coated versions or taking with food helps mild issues, but doesn't eliminate risk.
  
• Short-term tolerance: Symptoms often improve or stay manageable with monitoring.
  
  

When Doctors Advise Stopping or Switching

If bleeding occurs, guidelines recommend pausing aspirin and using proton pump inhibitors (PPIs) like omeprazole to protect the stomach—PPIs reduce ulcer risk by 70-90% when combined with aspirin.[4] For low-risk patients, newer antiplatelets like clopidogrel may replace it, though they're costlier.

Balancing Risks: What the Data Shows

| Scenario | Continue Aspirin? | Key Evidence |
|----------|-------------------|--------------|
| History of heart attack/stent | Yes, usually with PPI | Reduces repeat events by 25%; GI bleed risk ~1%/year[5] |
| Primary prevention (no prior event) | Often no, especially >70 | Benefits marginal; bleed risk higher[6] |
| Active ulcer/bleed | Stop immediately | Restart only after healing |

Patients discuss trade-offs with doctors via tools like the HAS-BLED score for bleed risk vs. CHA2DS2-VASc for clot risk.

Sources
[1]: USPSTF Aspirin Guidelines
[2]: NEJM: Aspirin GI Risks
[3]: AHA/ACC Guidelines
[4]: Cochrane PPI Review
[5]: Lancet Meta-Analysis
[6]: JAMA Primary Prevention Trial